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Dear Colleagues,
We are happy to bring to you the second issue of 
“Clinical Diabetology” in 2018. I am convinced that 
you will find the articles contained in this issue use-
ful for both clinical practice and research. However, 
I would like to go back to the previous issue, which 
includes the 2018 Diabetes Poland (PTD) Guidelines 
on the management of diabetic patients. I am very 
glad that thanks to the efforts of the entire team of 
experts working under the guidance of Prof. Dorota 
Zozulińska-Ziółkiewicz these Guidelines were published 
in print, as scheduled, in January — at the beginning of 
the year. First and foremost we all feel the satisfaction 
of work well-done and the fact that we managed to 
take a step towards ensuring that the PTD Guidelines 
become a model to follow in creating guidelines in 
our country. I am referring to early inclusion of the 
results of the most important clinical trials and other 
scientific reports, being in line with the principles of 
Evidence Based Medicine (EBM) (levels of evidence 
underlying the recommendations), multidisciplinary 
nature of the group of experts and transparency in 
the process of developing the Guidelines. This year’s 
edition of the PTD Guidelines was sent to the Minister 
of Health and the President of the Agency for Health 
Technology Assessment and Tariff System (AOTMiT), 
with hope that they may become useful in developing 
general principles for the development of clinical re-
commendations in Poland.
I am also pleased to inform you that as a result 
of the arrangements with the publisher, the journal 
“Clinical Diabetology” has become fully available to all 





I am sure that, as every year, the PTD Guidelines will 
be a helpful tool in everyday work with diabetic patients.
Kind regards,
Prof. Maciej Małecki
President of the Diabetes Poland

